Uveitis im Kindes- und Jugendalter

Zusammenfassung

Intraokulare Entzündungen sind im Kindesalter eine der häufigsten Ursachen gesetzlicher Blindheit in Europa. Daher kommt der Diagnostik und Behandlung der Uveitis im Kindesalter besondere Bedeutung zu. Der oft asymptomatische Beginn der Entzündung und die dadurch verzögerte Diagnose führen nicht selten zu einer funktionell schlechteren Prognose gegenüber Erkrankungen im späteren Lebensalter. Bei etwa 20–30 % betroffener Augen verbleiben irreversible Schäden. Ziel dieses Beitrages ist es, auf die diagnostischen und therapeutischen Besonderheiten einzugehen, um Risiken und Komplikationen auf ein Minimum zu reduzieren.

Summary

Intraocular inflammation during childhood remains a significant cause of visual impairment in Europe. Therefore early diagnosis and treatment are essential. Because of its often asymptomatic course and delayed detection uveitis in childhood frequently results in a poorer prognosis as compared to later onset. As a consequence about 20–30 % of affected eyes may suffer irreversible damage. Aim of this article is to provide insights in the characteristics of diagnosis and treatment in childhood uveitis to minimize the risks of secondary complications.

Schlüsselwörter

Uveitis - intraokulare Entzündungen - Blindheit

Keywords

Uveitis - intraocular inflammation - visual impairment

• Literatur

• 1 BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol 2005; 89: 444-448.
• 2 Bertelmann E, Velhagen KH, Pleyer U. Ocular toxocariasis. From biology to therapy. Ophthalmologe 2007; 104: 35-39.
• 3 Borlu M, Uksal Ü Ferahbas A. et al. Clinical features of Behçet´s disease in children. Int J Dermatol 2006; 45: 713-716.
• 4 Dobner BC, Max R, Becker MD. et al. A three-centre experience with adalimumab for the treatment of non-infectious uveitis. Br J Ophthalmol 2013; 97: 134-138.
• 5 Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the northern California Epidemiology of Uveitis Study. Ophthalmology 2004; 111: p491-500. discussion 500
• 6 Häfner R, Vogel P. Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol 1993; 11: 685-691.
• 7 Hazirolan D, Pleyer U. Think global - act local: intravitreal drug delivery systems in chronic non-infectious uveitis. Ophthalmic Res 2013; 49: 59-65.
• 8 Heiligenhaus A, Michels H, Schumacher C. et al. Evidence-based, interisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int 2012; 32: 1121-1133.
• 9 Heiligenhaus A, Wefelmeyer D, Wefelmeyer E. et al. The eye as a common site fort he early clinical manifestation of sarcoidosis. Ophthalmic Res 2011; 46: 9-12.
• 10 Heinz C, Pleyer U, Ruokonen P, Heiligenhaus A. Secondary glaucoma in childhood uveitis. Ophthalmologe 2008; 105: 438-444.
• 11 Hofley P, Roarty J, McGinnity G. et al. Asymptomatic uveitis in children with chronic inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 1993; 17: 397-400.
• 12 Hudde T, Neudorf UHeiligenhaus. et al Diagnostic in childhood uveitis: what tests for which uveitis?. Klin Monbl Augenheilkd 2007; 224: 494-499.
• 13 Huppertz HI, Munchmeier D, Lieb W. Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophthalmol 1999; 83: 1149-1152.
• 14 Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509-516.
• 15 Kakkassery V, Mergler S, Pleyer U. Anti-TNF-alpha treatment: a possible promotor in endogenous uveitis? Observational report on six patients: occurrence of uveitis following etanercept treatment. Curr Eye Res 2010; 35: 751-756.
• 16 Kotaniemi K, Kautiainen H, Karma A. et al. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis. A prospective study. Ophthalmology 2001; 108: 2071-2075.
• 17 Kotaniemi K, Aho K, Kotaniemi A. Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol 2001; 28: 309-312.
• 18 Kotaniemi K, Penttila H. Intraocular lens implantation in patients with juvenile idiopathic arthtritis-associated uveitis. Ophthalmic Res 2006; 38: 318-323.
• 19 Krause I, Uziel Y, Guedj D. et al. Childhood Behçet´s disease: clinical features and comparison with adult-onset disease. Rheumatology 1999; 38: 457-462.
• 20 Krumpaszky HG. Temporal trends in the etiology of blindness. Klin Monbl Augenheilkd 1997; 210: aA9-16.
• 21 Kump LI, Cervantes-Castaneda RA, Androudi SN, Foster CS. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology 2005; 112: 1287-1292.
• 22 Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997; 115: 61-64.
• 23 Malagon C, Van Kerckhove C, Giannini EH. et al. The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients. J Rheumatol 1992; 19: 160-163.
• 24 Michels H, Greiner K, Heinz C. et al. Andere entzündlich rheumatische Erkrankungen mit Uveitis neben der juvenilen idiopathischen Arthritis. Klin Monatsbl Augenheilk 2007; 224: 473-476.
• 25 Minden K, Mingels A, Niewerth M. et al. Juvenile idiopathische Arthritis und Uveitis: Epidemiologie einschließlich der Daten aus der Kerndokumentation. Klin Monatsbl Augenheilk 2007; 224: 469-472.
• 26 Mingels A, Hudde T, Heinz C. et al. Vision threatening complications in uveitis in childhood. Ophthalmologe 2005; 105: 477-484.
• 27 Neri P, Eandi C, Arapi I. et al. Long-term control of non-infectious paediatric panuveitis refractory to traditional immunesuppressive therapy successfully treated with Adalimumab (HumiraTM). Clin Exp Rheumatol 2013; 31: 458-462. Epub 2013 Mar 4
• 28 Pleyer U, Priem S, Bergmann L. et al. Detection of Borrelia burgdorferi DNA in Urine of patients with ocular Lyme borreliosis. Br J Ophthalmol 2001; 85: 552-555.
• 29 Pleyer U, Torun N, Liesenfeld O. Ocular toxoplasmosis. Ophthalmologe 2007; 104: 603-615. quiz 616
• 30 Saarela V, Nuutinen M, Ala Houhala M. et al. Tubulointerstitial nephritis and uveitis syndrome in children: a prospective multicenter study. Ophthalmology 2013; 120: 1476-1481.
• 31 Shobab L, Pleyer U, Johnsen J. et al. Toxoplasma Serotype is associated with development of ocular Toxoplasmosis. J Infect Dis 2013; 208: 1520-1528.
• 32 Simonini G, Xu Z, Caputo R. et al. Clinical and transcriptional response to the long acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum 2013; 65: 513-518.
• 33 Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behçet disease: a descriptive study of 36 cases. Am J Ophthalmol 2003; 136: 1114-1119.
• 34 Kallnich TK. Periodische Fiebersyndrome. In: Wagner G. (Hrsg). Pädiatische Rheumatologie. Berlin, Heidelberg: Springer; 2007: 407-434.